® 2005 Advanced Medical Optics, Inc., Santa Ana, CA 92705 AMO, the AMO logo, and Innovating Vision are trademarks of Advanced Medical Optics, Inc. OptiEdge is a trademark of Ocular Sciences, Inc. CLARIFLEX™ lenses are produced and/or sold under at least one of the following U.S. Patents Nos.: 5,236,970; 5,376,694; 5,476,513; 5,494,946; 5,661,195; 5,869,549; 6,162,249; 6,277,147; 6,468,306; 6,648,741; and 6,692,525. European patent 1,246,586. Patents pending and foreign equivalents available upon request. ClariFlex® IOL Package Insert Intended Use Statement: The ClariFlex Silicone Posterior Chamber Intraocular Lenses are indicated for primary implantation for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed by phacoemulsification. Precautions: Do not resterilize the lens; do not soak or rinse the lens with any solution other than sterile saline solution; do not store the lens in direct sunlight. Warnings: Surgeons should consider the risk/benefit ratio for adults with preoperative ocular pathology, including but not limited to inflammation, distorted eye, and microbial infection. Adverse Events: Adverse events that have been documented as having occurred following intraocular lens implantation include but are not limited to corneal edema, iritis, lens dislocation, hyphema, macular edema, and retinal detachment. For a complete list of precautions, warnings and adverse events, refer to the package insert. Rx Only.